rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2006-5-8
|
pubmed:abstractText |
The EUROpean Ewing tumour Working Initiative of National Groups 1999 (EURO-E.W.I.N.G. 99) protocol prescribes six courses of vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) as intensive induction chemotherapy for Ewing tumors (ET). Granulocyte-colony stimulating factor (G-CSF) is recommended. Adverse reactions (AR) were evaluated; quality assurance of data collection reviewed.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1545-5009
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright 2006 Wiley-Liss, Inc.
|
pubmed:issnType |
Print
|
pubmed:volume |
47
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
22-9
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:16572419-Adolescent,
pubmed-meshheading:16572419-Adult,
pubmed-meshheading:16572419-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:16572419-Bone Neoplasms,
pubmed-meshheading:16572419-Child,
pubmed-meshheading:16572419-Clinical Trials as Topic,
pubmed-meshheading:16572419-Doxorubicin,
pubmed-meshheading:16572419-Drug Toxicity,
pubmed-meshheading:16572419-Etoposide,
pubmed-meshheading:16572419-Female,
pubmed-meshheading:16572419-Humans,
pubmed-meshheading:16572419-Ifosfamide,
pubmed-meshheading:16572419-Male,
pubmed-meshheading:16572419-Middle Aged,
pubmed-meshheading:16572419-Sarcoma, Ewing,
pubmed-meshheading:16572419-Statistics, Nonparametric,
pubmed-meshheading:16572419-Vincristine
|
pubmed:year |
2006
|
pubmed:articleTitle |
Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G. 99 clinical trial.
|
pubmed:affiliation |
Coordinating Centre for Clinical Trials (KKS), University of Muenster, Muenster, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Evaluation Studies
|